1. Lestrade P, Meis JF, Arends JP, Beek MT, Brauwer E, Dijk K,
et al. Diagnosis and management of aspergillosis in the
Netherlands: a national survey. Mycoses. 2016;59(2):101-7.
2. Chowdhary A, Sharma C, Meis JF. Azole-resistant aspergillosis:
epidemiology, molecular mechanisms, and treatment. The
Journal of infectious diseases. 2017;216(suppl_3):S436-S44.
3. van der Linden J, Arendrup M, Warris A, Lagrou K, Pelloux
H, Hauser P, et al. Prospective Multicenter International
Surveillance of Azole Resistance in Aspergillus fumigatus.
Emerging infectious diseases. 2015;21(6):1041-4.
4. Patterson TF, Thompson III GR, Denning DW, Fishman JA,
Hadley S, Herbrecht R, et al. Practice guidelines for the
diagnosis and management of aspergillosis: 2016 update by the
Infectious Diseases Society of America. Clinical infectious
diseases. 2016;63(4):e1-e60.
5. Mortensen KL, Jensen RH, Johansen HK, Skov M, Pressler T,
Howard SJ, et al. Aspergillus species and other moulds in
respiratory samples from cystic fibrosis patients: a laboratorybased study with focus on azole resistance in Aspergillus
fumigatus. Journal of clinical microbiology. 2011:JCM. 00213-11.
6. Nasri E, Fakhim H, Vaezi A, Khalilzadeh S, Ahangarkani F,
Laal kargar M, et al. Airway colonisation by Candida and
Aspergillus species in Iranian cystic fibrosis patients. Mycoses.
2019;62(5):434-40.
7. Burgel P-R, Baixench M-T, Amsellem M, Audureau E, Chapron
J, Kanaan R, et al. High prevalence of azole-resistant Aspergillus
fumigatus in adults with cystic fibrosis exposed to itraconazole.
Antimicrobial agents and chemotherapy. 2012;56(2):869-74.
8. Fuhren J, Voskuil W, Boel C, Haas P, Hagen F, Meis J, et al.
High prevalence of azole resistance in Aspergillus fumigatus
isolates from high-risk patients. Journal of Antimicrobial
Chemotherapy. 2015;70(10):2894-8.
9. Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC,
Pasqualotto AC, et al. Frequency and evolution of azole
resistance in Aspergillus fumigatus associated with treatment
failure. Emerging infectious diseases. 2009;15(7):1068.
10. Arendrup MC, Mavridou E, Mortensen KL, Snelders E,
Frimodt-Moller N, Khan H, et al. Development of azole
resistance in Aspergillus fumigatus during azole therapy
associated with change in virulence. PLoS One. 2010;
5(4):e10080.
11. Badali H, Vaezi A, Haghani I, Yazdanparast SA, Hedayati MT,
Mousavi B, et al. Environmental study of azole‐resistant
Aspergillus fumigatus with TR34/L98H mutations in the cyp51A
gene in Iran. Mycoses. 2013;56(6):659-63.
12. Zarrinfar H, Mirhendi H, Makimura K, Satoh K, Khodadadi H,
Paknejad O. Use of mycological, nested PCR, and real-time
PCR methods on BAL fluids for detection of Aspergillus
fumigatus and A. flavus in solid organ transplant recipients.
Mycopathologia. 2013;176(5-6):377-85.
13. Zarrinfar H, Mirhendi H, Fata A, Khodadadi H, Kordbacheh P.
Detection of Aspergillus flavus and A. fumigatus in
bronchoalveolar lavage specimens of hematopoietic stem cell
transplants and hematological malignancies patients by real-time
polymerase chain reaction, nested PCR and mycological assays.
Jundishapur Journal of Microbiology. 2015;8(1).
14. Diba K, Makhdoomi K, Mirhendi H. Molecular characterization
of Aspergillus infections in an Iranian educational hospital using
RAPD-PCR method. Iranian journal of basic medical sciences.
2014;17(9):646.
15. Rivero-Menendez O, Soto-Debran JC, Medina N, Lucio J,
Mellado E, Alastruey-Izquierdo A. Molecular identification,
antifungal susceptibility testing, and mechanisms of azole
resistance in Aspergillus species received within a surveillance
program on antifungal resistance in Spain. Antimicrobial agents
and chemotherapy. 2019;63(9):e00865-19.
16. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R,
Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis:
clinical practice guidelines of the Infectious Diseases Society of
America. Clinical infectious diseases. 2008;46(3):327-60.
17. Ahangarkani F, Puts Y, Nabili M, Khodavaisy S, Moazeni M,
Salehi Z, et al. First azole‐resistant Aspergillus fumigatus
isolates with the environmental TR46/Y121F/T289A mutation in Iran. Mycoses. 2020;63(5):430-6.
18. Van der Linden J, Arendrup M, Warris A, Lagrou K, Pelloux H,
Hauser P, et al. Prospective multicenter international surveillance
of azole resistance in Aspergillus fumigatus. Emerging infectious
diseases. 2015;21(6):1041.
19. De Valk H, Klaassen C, Meis J. Molecular typing of Aspergillus
species. Mycoses. 2008;51(6):463-76.
20. Vanhee LM, Nelis HJ, Coenye T. What can be learned from
genotyping of fungi? Medical Mycology. 2010;48(sup1):S60-S9.
21. Klaassen C. MLST versus microsatellites for typing Aspergillus
fumigatus isolates. Medical Mycology. 2009;47(sup1):S27-S33.
22. Ahangarkani F, Badali H, Abbasi K, Nabili M, Khodavaisy S, de
Groot T, et al. Clonal Expansion of Environmental Triazole
Resistant Aspergillus fumigatus in Iran. Journal of Fungi.
2020;6(4):199.
23. de Valk HA, Klaassen CH, Yntema J-B, Hebestreit A, Seidler
M, Haase G, et al. Molecular typing and colonization patterns of
Aspergillus fumigatus in patients with cystic fibrosis. Journal of
Cystic Fibrosis. 2009;8(2):110-4.
24. Nabili M, Shokohi T, Moazeni M, Khodavaisy S, Aliyali M,
Badiee P, et al. High prevalence of clinical and environmental
triazole-resistant Aspergillus fumigatus in Iran: is it a
challenging issue? Journal of medical microbiology.
2016;65(6):468-75.
25. de Valk HA, Meis JF, Curfs IM, Muehlethaler K, Mouton JW,
Klaassen CH. Use of a novel panel of nine short tandem repeats
for exact and high-resolution fingerprinting of Aspergillus
fumigatus isolates. Journal of clinical microbiology. 2005;
43(8):4112-20.
26. Khodavaisy S, Badali H, Rezaie S, Nabili M, Moghadam KG,
Afhami S, et al. Genotyping of clinical and environmental
Aspergillus flavus isolates from Iran using microsatellites.
Mycoses. 2016;59(4):220-5.
27. Simpson EH. Measurement of diversity. nature. 1949;
163(4148):688-.
28. Hedayati MT, Khodavaisy S, Alialy M, Omran SM, Habibi MR.
Invasive aspergillosis in intensive care unit patients in Iran. Acta
Medica (Hradec Kralove). 2013;56(2):52-6.
29. Aliyali M, Badali H, Shokohi T, Moazeni M, Nosrati A,
Godazandeh G, et al. Coinfection of Pulmonary Hydatid Cyst
and Aspergilloma: Case Report and Systematic Review.
Mycopathologia. 2015:1-11.
30. Nabili M, Shokohi T, Janbabaie G, Hashemi-Soteh MB, AliMoghaddam K, Aghili SR. Detection of invasive aspergillosis in
bone marrow transplant recipients using real-time PCR. Journal
of global infectious diseases. 2013;5(2):68.
31. Nabili M, Shokohi T, Jan Babaei G, Ali Moghaddam K,
Ghavamzadeh A. Evaluation of Galactomannan Assay in Serum
for Detection of Invasive Aspergillosis in Patients with
Hematologic Malignancies and Bone Marrow Transplant
Recipients. Journal of Mazandaran University of Medical
Sciences. 2012;22(87):10-20.
32. Babamahmoodi F, Shokohi T, Ahangarkani F, Nabili M,
Afzalian Ashkezari E, Alinezhad S. Rare Case of Aspergillus
ochraceus Osteomyelitis of Calcaneus Bone in a Patient with
Diabetic Foot Ulcers. Case reports in medicine. 2015;2015.
33. Zarrinfar H, Makimura K, Satoh K, Khodadadi H, Mirhendi H.
Incidence of Pulmonary Aspergillosis and Correlation of
Conventional Diagnostic Methods with Nested PCR and
Real‐Time PCR Assay Using BAL Fluid in Intensive Care Unit
Patients. Journal of clinical laboratory analysis. 2013;27(3):181-5.
34. Zarrinfar H, Saber S, Kordbacheh P, Makimura K, Fata A,
Geramishoar M, et al. Mycological microscopic and culture
examination of 400 bronchoalveolar lavage (BAL) samples.
Iranian journal of public health. 2012;41(7):70.
35. Vonberg RP, Gastmeier P. Nosocomial aspergillosis in outbreak
settings. Journal of Hospital Infection. 2006;63(3):246-54.
36. Moazeni M, Asgari S, Nabili M. Nosocomial fungal infections:
Epidemiology, diagnosis, treatment and prevention. Journal of
Mazandaran University of Medical Sciences. 2018;28(160):
182-212.
37. Snelders E, Melchers WJ, Verweij PE. Azole resistance in
Aspergillus fumigatus: a new challenge in the management of
invasive aspergillosis? Future microbiology. 2011;6(3):335-47.
38. Varga J. Molecular typing of aspergilli: Recent developments
and outcomes. Medical Mycology. 2006;44(sup1):149-61.
39. Debeaupuis J-P, Sarfati J, Chazalet V, Latge J-P. Genetic
diversity among clinical and environmental isolates of
Aspergillus fumigatus. Infection and Immunity. 1997;65(8):
3080-5.
40. Lasker BA. Evaluation of performance of four genotypic
methods for studying the genetic epidemiology of Aspergillus
fumigatus isolates. Journal of clinical microbiology. 2002;
40(8):2886-92.
41. Warris A, Klaassen CH, Meis JF, de Ruiter MT, de Valk HA,
Abrahamsen TG, et al. Molecular epidemiology of Aspergillus
fumigatus isolates recovered from water, air, and patients shows
two clusters of genetically distinct strains. Journal of Clinical
Microbiology. 2003;41(9):4101-6.
42. Kidd SE, Ling LM, Meyer W, Morrissey CO, Chen SC, Slavin
MA. Molecular epidemiology of invasive aspergillosis: lessons
learned from an outbreak investigation in an Australian
hematology unit. Infection Control & Hospital Epidemiology.
2009;30(12):1223-6.
43. Balajee SA, de Valk HA, Lasker BA, Meis JF, Klaassen CH.
Utility of a microsatellite assay for identifying clonally related
outbreak isolates of Aspergillus fumigatus. Journal of
microbiological methods. 2008;73(3):252-6.
44. Khodavaisy S, Rezaie S, Ahmadi M, Hassanpour Z, Roshan R,
Falahatinejad M, et al. A Review on Molecular Typing Methods
for Aspergillus Species. Journal of Mazandaran University of
Medical Sciences. 2015;25(129):165-80.
45. Guarro J, Solé M, Castany R, Cano J, Teixidó A, Pujol I, et al.
Use of random amplified microsatellites to type isolates from an
outbreak of nosocomial aspergillosis in a general medical ward.
Medical mycology. 2005;43(4):365-71.
46. Bart-Delabesse E, Cordonnier C, Bretagne S. Usefulness of
genotyping with microsatellite markers to investigate hospitalacquired invasive aspergillosis. Journal of Hospital Infection.
1999;42(4):321-7.
47. Chowdhary A, Kathuria S, Xu J, Sharma C, Sundar G, Singh
PK, et al. Clonal expansion and emergence of environmental
multiple-triazole-resistant Aspergillus fumigatus strains carrying
the TR 34/L98H mutations in the cyp 51A gene in India. PLoS
One. 2012;7(12):e52871.
)
